183 related articles for article (PubMed ID: 22170867)
1. Enhanced meta-analysis of acetylcholine binding protein structures reveals conformational signatures of agonism in nicotinic receptors.
Stober ST; Abrams CF
Protein Sci; 2012 Mar; 21(3):307-17. PubMed ID: 22170867
[TBL] [Abstract][Full Text] [Related]
2. Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations.
Hansen SB; Sulzenbacher G; Huxford T; Marchot P; Taylor P; Bourne Y
EMBO J; 2005 Oct; 24(20):3635-46. PubMed ID: 16193063
[TBL] [Abstract][Full Text] [Related]
3. Galanthamine and non-competitive inhibitor binding to ACh-binding protein: evidence for a binding site on non-alpha-subunit interfaces of heteromeric neuronal nicotinic receptors.
Hansen SB; Taylor P
J Mol Biol; 2007 Jun; 369(4):895-901. PubMed ID: 17481657
[TBL] [Abstract][Full Text] [Related]
4. Structural determinants of selective alpha-conotoxin binding to a nicotinic acetylcholine receptor homolog AChBP.
Ulens C; Hogg RC; Celie PH; Bertrand D; Tsetlin V; Smit AB; Sixma TK
Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3615-20. PubMed ID: 16505382
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of Lymnaea stagnalis AChBP complexed with the potent nAChR antagonist DHβE suggests a unique mode of antagonism.
Shahsavar A; Kastrup JS; Nielsen EØ; Kristensen JL; Gajhede M; Balle T
PLoS One; 2012; 7(8):e40757. PubMed ID: 22927902
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
Brejc K; van Dijk WJ; Klaassen RV; Schuurmans M; van Der Oost J; Smit AB; Sixma TK
Nature; 2001 May; 411(6835):269-76. PubMed ID: 11357122
[TBL] [Abstract][Full Text] [Related]
7. The 2.7 A structure of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor.
Brejc K; van Dijk WJ; Smit AB; Sixma TK
Novartis Found Symp; 2002; 245():22-9; discussion 29-32, 165-8. PubMed ID: 12027010
[TBL] [Abstract][Full Text] [Related]
8. Acetylcholine binding protein (AChBP) as template for hierarchical in silico screening procedures to identify structurally novel ligands for the nicotinic receptors.
Akdemir A; Rucktooa P; Jongejan A; Elk Rv; Bertrand S; Sixma TK; Bertrand D; Smit AB; Leurs R; de Graaf C; de Esch IJ
Bioorg Med Chem; 2011 Oct; 19(20):6107-19. PubMed ID: 21920761
[TBL] [Abstract][Full Text] [Related]
9. A model for short alpha-neurotoxin bound to nicotinic acetylcholine receptor from Torpedo californica: comparison with long-chain alpha-neurotoxins and alpha-conotoxins.
Mordvintsev DY; Polyak YL; Levtsova OV; Tourleigh YV; Kasheverov IE; Shaitan KV; Utkin YN; Tsetlin VI
Comput Biol Chem; 2005 Dec; 29(6):398-411. PubMed ID: 16290328
[TBL] [Abstract][Full Text] [Related]
10. Atypical nicotinic agonist bound conformations conferring subtype selectivity.
Tomizawa M; Maltby D; Talley TT; Durkin KA; Medzihradszky KF; Burlingame AL; Taylor P; Casida JE
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1728-32. PubMed ID: 18230720
[TBL] [Abstract][Full Text] [Related]
11. Polypeptide and peptide toxins, magnifying lenses for binding sites in nicotinic acetylcholine receptors.
Tsetlin V; Utkin Y; Kasheverov I
Biochem Pharmacol; 2009 Oct; 78(7):720-31. PubMed ID: 19501053
[TBL] [Abstract][Full Text] [Related]
12. Design and expression of human alpha7 nicotinic acetylcholine receptor extracellular domain mutants with enhanced solubility and ligand-binding properties.
Zouridakis M; Zisimopoulou P; Eliopoulos E; Poulas K; Tzartos SJ
Biochim Biophys Acta; 2009 Feb; 1794(2):355-66. PubMed ID: 19059502
[TBL] [Abstract][Full Text] [Related]
13. Multiple interaction regions in the orthosteric ligand binding domain of the α7 neuronal nicotinic acetylcholine receptor.
Xiao Y; Hammond PS; Mazurov AA; Yohannes D
J Chem Inf Model; 2012 Nov; 52(11):3064-73. PubMed ID: 23092444
[TBL] [Abstract][Full Text] [Related]
14. Structural determinants for interaction of partial agonists with acetylcholine binding protein and neuronal alpha7 nicotinic acetylcholine receptor.
Hibbs RE; Sulzenbacher G; Shi J; Talley TT; Conrod S; Kem WR; Taylor P; Marchot P; Bourne Y
EMBO J; 2009 Oct; 28(19):3040-51. PubMed ID: 19696737
[TBL] [Abstract][Full Text] [Related]
15. Ligand-induced conformational changes in the acetylcholine-binding protein analyzed by hydrogen-deuterium exchange mass spectrometry.
Shi J; Koeppe JR; Komives EA; Taylor P
J Biol Chem; 2006 Apr; 281(17):12170-7. PubMed ID: 16484218
[TBL] [Abstract][Full Text] [Related]
16. Atomic interactions of neonicotinoid agonists with AChBP: molecular recognition of the distinctive electronegative pharmacophore.
Talley TT; Harel M; Hibbs RE; Radic Z; Tomizawa M; Casida JE; Taylor P
Proc Natl Acad Sci U S A; 2008 May; 105(21):7606-11. PubMed ID: 18477694
[TBL] [Abstract][Full Text] [Related]
17. Use of acetylcholine binding protein in the search for novel alpha7 nicotinic receptor ligands. In silico docking, pharmacological screening, and X-ray analysis.
Ulens C; Akdemir A; Jongejan A; van Elk R; Bertrand S; Perrakis A; Leurs R; Smit AB; Sixma TK; Bertrand D; de Esch IJ
J Med Chem; 2009 Apr; 52(8):2372-83. PubMed ID: 19331415
[TBL] [Abstract][Full Text] [Related]
18. Partial activation of α7 nicotinic acetylcholine receptors: insights from molecular dynamics simulations.
Shi C; Yu R; Shao S; Li Y
J Mol Model; 2013 Feb; 19(2):871-8. PubMed ID: 23086458
[TBL] [Abstract][Full Text] [Related]
19. Conformational changes in acetylcholine binding protein investigated by temperature accelerated molecular dynamics.
Mohammad Hosseini Naveh Z; Malliavin TE; Maragliano L; Cottone G; Ciccotti G
PLoS One; 2014; 9(2):e88555. PubMed ID: 24551117
[TBL] [Abstract][Full Text] [Related]
20. Structural characterization of agonist and antagonist-bound acetylcholine-binding protein from Aplysia californica.
Hansen SB; Sulzenbacher G; Huxford T; Marchot P; Bourne Y; Taylor P
J Mol Neurosci; 2006; 30(1-2):101-2. PubMed ID: 17192647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
